Cited by 240Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsMedical Imaging Techniques and Applications

Early stages of tau pathology and its associations with functional connectivity, atrophy and memory

Open access
Berron, David, Vogel, Jacob W, Insel, Philip S, Pereira, Joana B, Xie, Long, Wisse, Laura E M, Yushkevich, Paul A, Palmqvist, Sebastian +5 more·2021·Brain

Abstract

In Alzheimer’s disease, post-mortem studies have shown that the first cortical site where neurofibrillary tangles appear is the transentorhinal region, a subregion within the medial temporal lobe that largely overlaps with Brodmann area 35, and the entorhinal cortex. Here we used tau-PET imaging to investigate the sequence of tau pathology progression within the human medial temporal lobe and across regions in the posterior-medial system. Our objective was to study how medial temporal tau is related to functional connectivity, regional atrophy, and memory performance. We included 215 amyloid-β− cognitively unimpaired, 81 amyloid-β+ cognitively unimpaired and 87 amyloid-β+ individuals with mild cognitive impairment, who each underwent 18F-RO948 tau and 18F-flutemetamol amyloid PET imaging, structural T1-MRI and memory assessments as part of the Swedish BioFINDER-2 study. First, event-based modelling revealed that the entorhinal cortex and Brodmann area 35 show the earliest signs of tau accumulation followed by the anterior and posterior hippocampus, Brodmann area 36 and the parahippocampal cortex. In later stages, tau accumulation became abnormal in neocortical temporal and finally parietal brain regions. Second, in cognitively unimpaired individuals, increased tau load was related to local atrophy in the entorhinal cortex, Brodmann area 35 and the anterior hippocampus and tau load in several anterior medial temporal lobe subregions was associated with distant atrophy of the posterior hippocampus. Tau load, but not atrophy, in these regions was associated with lower memory performance. Further, tau-related reductions in functional connectivity in critical networks between the medial temporal lobe and regions in the posterior-medial system were associated with this early memory impairment. Finally, in patients with mild cognitive impairment, the association of tau load in the hippocampus with memory performance was partially mediated by posterior hippocampal atrophy. In summary, our findings highlight the progression of tau pathology across medial temporal lobe subregions and its disease stage-specific association with memory performance. While tau pathology might affect memory performance in cognitively unimpaired individuals via reduced functional connectivity in critical medial temporal lobe-cortical networks, memory impairment in mild cognitively impaired patients is associated with posterior hippocampal atrophy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awab114

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 52

  1. [2]Maass A, Lockhart SN, Harrison TM, et al Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging. J Neurosci. 2018; 38(3): 530– 543. 29192126 PMC5777108
  2. [3]Ritchey M, Libby LA, Ranganath C. Progress in brain research. Progr Brain Res. 2015; 219: 45– 64. 26072233
  3. [4]Ranganath C, Ritchey M. Two cortical systems for memory-guided behaviour. Nat Rev Neurosci. 2012; 13(10): 713– 726. 22992647
  4. [5]Palmqvist S, Schöll M, Strandberg O, et al Earliest accumulation of amyloid-β occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun. 2017; 8(1): 1214. 29089479 PMC5663717
  5. [6]Mattsson N, Palmqvist S, Stomrud E, Vogel J, Hansson O. Staging β-amyloid pathology with amyloid positron emission tomography. JAMA Neurol. 2019; 76(11): 1319. 31314895 PMC6646987
  6. [7]Maass A, Berron D, Harrison TM, et al Alzheimer’s pathology targets distinct memory networks in the ageing brain. Brain. 2019; 142(8): 2492– 2509. 31199481 PMC6658874
  7. [8]Braak H, Braak E. Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging. 1995; 16(3): 271– 278. 7566337
  8. [10]Braak H, Tredici KD. From the entorhinal region via the prosubiculum to the dentate fascia: Alzheimer disease-related neurofibrillary changes in the temporal allocortex. J Neuropathol Exper Neurol. 2020; 79(2): 163– 175. 31913466 PMC6970449
  9. [11]Pascoal TA, Therriault J, Benedet AL, et al 18F-MK-6240 PET for early and late detection of neurofibrillary tangles. Brain. 2020; 143(9): 2818– 2830. 32671408
  10. [12]Ossenkoppele R, Rabinovici GD, Smith R, et al Discriminative accuracy of [18 F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2018; 320(11): 1151. 30326496 PMC6233630
  11. [13]Bejanin A, Schonhaut DR, Joie R, et al Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease. Brain. 2017; 140(12): 3286– 3300. 29053874 PMC5841139
  12. [14]Xie L, Das SR, Wisse L, et al; Alzheimer’s Disease Neuroimaging Initiative. Early tau burden correlates with higher rate of atrophy in transentorhinal cortex. J Alzheimers Dis. 2018; 62(1): 85– 92. 29439350 PMC5880816
  13. [15]Joie RL, Visani AV, Baker SL, et al Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020; 12(524): eaau5732. 31894103 PMC7035952
  14. [16]Berron D, van Westen D, Ossenkoppele R, Strandberg O, Hansson O. Medial temporal lobe connectivity and its associations with cognition in early Alzheimer’s disease. Brain. 2020; 143(4): 1233– 1248. 32252068 PMC7174043
  15. [18]Young AL, Oxtoby NP, Daga P, et al A data-driven model of biomarker changes in sporadic Alzheimer’s disease. Brain. 2014; 137(9): 2564– 2577. 25012224 PMC4132648
  16. [19]Xie L, Wisse LEME, Pluta J, et al; for the Alzheimer's Disease Neuroimaging Initiative. Automated segmentation of medial temporal lobe subregions on in vivo T1-weighted MRI in early stages of Alzheimer’s disease. Hum Brain Mapping. 2019; 40(12): 3431– 3451. PMC6697377 31034738
  17. [20]Cho SH, Choe YS, Park S, et al Appropriate reference region selection of 18F-florbetaben and 18F-flutemetamol beta-amyloid PET expressed in Centiloid. Sci Rep. 2020; 10(1): 14950. 32917930 PMC7486392
  18. [21]Xie L, Pluta JB, Das SR, et al Multi-template analysis of human perirhinal cortex in brain MRI: Explicitly accounting for anatomical variability. Neuroimage. 2017; 144(Pt A): 183– 202. 27702610 PMC5183532
  19. [22]Baker SL, Maass A, Jagust WJ. Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data. Data Brief. 2017; 15(Acta Neuropathol): 648– 657. 29124088 PMC5671473
  20. [23]Rousset OG, Ma Y, Evans AC. Correction for partial volume effects in PET: Principle and validation. J Nucl Med. 1998; 39(5): 904– 911. 9591599
  21. [24]Thomas BA, Erlandsson K, Modat M, et al The importance of appropriate partial volume correction for PET quantification in Alzheimer’s disease. Eur J Nucl Med Mol. 2011; 38(6): 1104– 1119. 21336694
  22. [25]Thurfjell L, Lilja J, Lundqvist R, et al Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: Concordance with visual image reads. J Nucl Med. 2014; 55(10): 1623– 1628. 25146124
  23. [26]Fonteijn HM, Modat M, Clarkson MJ, et al An event-based model for disease progression and its application in familial Alzheimer’s disease and Huntington’s disease. Neuroimage. 2012; 60(3): 1880– 1889. 22281676
  24. [27]Vogel JW, Iturria-Medina Y, Strandberg OT, et al; Swedish BioFinder Study. Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease. Nat Commun. 2020; 11(1): 2612. 32457389 PMC7251068
  25. [28]Avants BB, Tustison NJ, Stauffer M, Song G, Wu B, Gee JC. The Insight ToolKit image registration framework. Front Neuroinform. 2014; 8: 44. 24817849 PMC4009425
  26. [29]Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage. 2007; 38(1): 95– 113. 17761438
  27. [30]Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM. FSL. Neuroimage. 2012; 62(2): 782– 790. 21979382
  28. [31]Cox RW. AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res Int J. 1996; 29(3): 162– 173. 8812068
  29. [32]Grabner G, Janke AL, Budge MM, Smith D, Pruessner J, Collins DL. Symmetric atlasing and model based segmentation: An application to the hippocampus in older adults. Med Image Comput Comp Assist Interv. 2006; 9(Pt 2): 58– 66. 17354756
  30. [33]Behzadi Y, Restom K, Liau J, Liu TT. A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. NeuroImage. 2007; 37(1): 90– 101. 17560126 PMC2214855
  31. [34]Friston KJ, Williams S, Howard R, Frackowiak RSJ, Turner R. Movement‐related effects in fMRI time‐series. Magnet Reson Med. 1996; 35(3): 346– 355. 8699946
  32. [35]Wang S, Peterson DJ, Gatenby JC, Li W, Grabowski TJ, Madhyastha TM. Evaluation of field map and nonlinear registration methods for correction of susceptibility artifacts in diffusion MRI. Front Neuroinform. 2017; 11: 17. 28270762 PMC5318394
  33. [36]Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage. 2012; 59(3): 2142– 2154. 22019881 PMC3254728
  34. [37]Fan L, Li H, Zhuo J, et al The human brainnetome atlas: A new brain atlas based on connectional architecture. Cereb Cortex. 2016; 26(8): 3508– 3526. 27230218 PMC4961028
  35. [38]Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry. 1984; 141(11): 1356– 1364. 6496779
  36. [40]Schönheit B, Zarski R, Ohm TG. Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging. 2004; 25(6): 697– 711. 15165691
  37. [41]Lace G, Savva GM, Forster G, et al Hippocampal tau pathology is related to neuroanatomical connections: An ageing population-based study. Brain. 2009; 132(5): 1324– 1334. 19321462
  38. [42]Ravikumar S, Wisse LEM, Ittyerah R et al Building an Ex Vivo Atlas of the Earliest Brain Regions Affected by Alzheimer’s Disease Pathology. In: 2020 IEEE 17th International Symposium on Biomedical Imaging. 2020: 113– 117.
  39. [43]Hokkanen SRK, Hunter S, Polvikoski TM, et al; MRC CFAS and CC75C Study Group. Hippocampal sclerosis, hippocampal neuron loss patterns and TDP-43 in the aged population: Population-based hippocampal neuron loss. Brain Pathol. 2018; 28(4): 548– 559. 28833898 PMC6099461
  40. [44]Insel PS, Mormino EC, Aisen PS, Thompson WK, Donohue MC. Neuroanatomical spread of amyloid β and tau in Alzheimer’s disease: Implications for primary prevention. Brain Commun. 2020; 2(1): fcaa007. 32140682 PMC7048875
  41. [45]Vogt LJK, Hyman BT, Hoesen GWV, Damasio AR. Pathological alterations in the amygdala in Alzheimer’s disease. Neurosci. 1990; 37(2): 377– 385. 2133349
  42. [46]Ritchey M, Cooper RA. Deconstructing the posterior medial episodic network. Trends Cogn Sci. 2020;24(6):451-465. 32340798
  43. [47]Das SR, Xie L, Wisse LE, et al; Alzheimer's Disease Neuroimaging Initiative. Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake. Neurobiol Aging. 2018; 66: 49– 58. 29518752 PMC5924615
  44. [48]Das SR, Xie L, Wisse L, et al In vivo measures of tau burden are associated with atrophy in early Braak stage medial temporal lobe regions in amyloid-negative individuals. Alzheimers Dem. 2019; 15: 1286– 1295. PMC6941656 31495603
  45. [49]de Flores R, Wisse LEM, Das SR, et al Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer’s disease. Alzheimers Dem. 2020;16(6): 843– 852. PMC7715004 32323446
  46. [50]Xie L, Wisse LEM, Das SR, et al; for the Alzheimer's Disease Neuroimaging Initiative. Longitudinal atrophy in early Braak regions in preclinical Alzheimer’s disease. Hum Brain Mapp. 2020; 41(16): 4704– 4717. 32845545 PMC7555086
  47. [51]Lindberg O, Mårtensson G, Stomrud E, et al Atrophy of the posterior subiculum is associated with memory impairment, tau- and amyloid-β pathology in non-demented individuals. Front Aging Neurosci. 2017; 9: 306. 28979205 PMC5611434
  48. [52]Witter MP, Amaral DG. The entorhinal cortex of the monkey: VI. Organization of projections from the hippocampus, subiculum, presubiculum and parasubiculum. J Comp Neurol. 2021; 529(4): 828– 852. 32656783 PMC8933866
  49. [53]Ferguson MA, Lim C, Cooke D, et al. A human memory circuit derived from brain lesions causing amnesia. Nat Commun. 2019;10(1):3497. PMC6677746 31375668
  50. [54]Harrison TM, Maass A, Adams JN, Du R, Baker SL, Jagust WJ. Tau deposition is associated with functional isolation of the hippocampus in aging. Nat Commun. 2019; 10(1): 4900. 31653847 PMC6814780
  51. [55]Kaboodvand N, Bäckman L, Nyberg L, Salami A. The retrosplenial cortex: a memory gateway between the cortical default mode network and the medial temporal lobe. Hum Brain Mapp. 2018; 39(5): 2020– 2034. 29363256 PMC6866613
  52. [56]Vogel JW, Young AL, Oxtoby NP, et al Characterizing the spatiotemporal variability of Alzheimer’s disease pathology. medRxiv. [Preprint] doi:10.1101/2020.08.20.2017 6883 · DOI

Cited by

Sorted by citations

Authors
Berron, D., Vogel, J. W., Insel, P. S., Pereira, J. B., Xie, L., Wisse, L. E. M., Yushkevich, P. A., Palmqvist, S., Mattsson-Carlgren, N., Stomrud, E., Smith, R., Strandberg, O., & Hansson, O.
Affiliations
  • Lund University (SE)
  • University of Pennsylvania (US)
  • University of California, San Francisco (US)
  • Karolinska Institutet (SE)
  • Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, 223 62 Lund, Sweden
Corresponding author
  • Berron, David
  • Hansson, Oskar
Venue
Brain
Published
2021-03-16
Volume
144
Issue
9
Pages
2771-2783
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W3139143010
Cited by
240
References
5
Citations by year
2026: 55 · 2025: 64 · 2024: 51 · 2023: 39 · 2022: 25 · 2021: 6
FWCI
21.70
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • Swedish Research Council
  • Alice Wallenberg foundation
  • Marianne and Marcus Wallenberg foundation
  • Strategic Research Brodmann area MultiPark
  • Swedish Alzheimer Foundation
  • Swedish Brain Foundation
  • The Parkinson foundation of Sweden
  • The Parkinson Research Foundation
  • Skåne University Hospital Foundation
  • European Union’s Horizon 2020 research and innovation programme
  • Marie Skłodowska-Curie (843074)
  • Alzheimer's Disease Research
  • BrightFocus Foundation
  • National Institutes of Health (T32MH019112)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
tau pathology, Alzheimer's disease, entorhinal cortex, hippocampus, functional connectivity, memory impairment, mild cognitive impairment, amyloid-beta, tau PET, 18F-flutemetamol, event-based modeling, disease progression
MeSH terms
Aged, Atrophy, Brain, Cross-Sectional Studies, Female, Humans, Magnetic Resonance Imaging, Male, Memory Disorders, Middle Aged, Nerve Net, tau Proteins, Positron-Emission Tomography, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review